Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Legal

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Legal
  • News
  • Short Sellers
  • Trading Ideas

FingerMotion Provides Litigation Update On Short Selling Research Firm

By Benzinga Newsdesk
November 17, 11:37 AM
FingerMotion, Inc. (NASDAQ:FNGR) (the "Company" or "FingerMotion"), a mobile services and data company, is providing a litigation update to the market regarding its newly filed lawsuit against Capybara Research

FNGR

Read More
2 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Johnson & Johnson Resolves 2 Major Talc Cases As Legal Battles Continue

By Vandana Singh
November 17, 10:25 AM
Johnson & Johnson (NYSE: JNJ) announced settlements in two talc-related cases, the news follows an appeals court's ruling which overturned a $223.8 million verdict

JNJ

Read More
1 minute read
  • Equities
  • Government
  • Legal
  • Management
  • Markets
  • Media
  • News
  • Regulations
  • Tech

Nvidia Rival Samsung’s Lee Jae-yong Faces Five-Year Jail Term: Report

By Anusuya Lahiri
November 17, 9:37 AM
South Korean prosecutors are reportedly seeking a five-year jail term for Samsung Electronics Ltd (OTC: SSNLF) boss Lee Jae-yong 

NVDA

Read More
2 minute read
  • General
  • Health Care
  • Legal
  • Media
  • News
  • Penny Stocks

Drugstore Chain Rite Aid Counters DOJ Lawsuit Amid Bankruptcy, Aiming To Safeguard Restructuring

By Vandana Singh
November 17, 8:37 AM
Rite Aid Corp (OTC: RADCQ), currently undergoing bankruptcy proceedings, has reportedly taken a legal stance against the U.S.

RADCQ

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Legal
  • Markets
  • News

Bayer’s Legal Victory Against Merck: Delaware Court Rules In Company’s Favor Regarding Talc Lawsuits

By Vandana Singh
November 17, 7:05 AM
The Delaware Supreme Court reportedly ruled in favor of Bayer AG (OTC: BAYRY) (OTC: BAYZF), stating that the company is not accountable for lawsuits associated with talc-based foot powder products obtained from Merck

BAYRY

Read More
2 minute read
  • Contracts
  • Legal
  • M&A
  • Management
  • News

Nasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business Combination

By Lara Goldstein
November 16, 5:07 PM
The duo comprised of clinical-stage natural psilocybin biotech Psyence Group Inc.

NCAC

Read More
2 minute read
  • Cannabis
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center

By Lara Goldstein
November 15, 5:20 PM
The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ: CMPS) for Treatment-Resistant Depression and Awakn Life Sciences (OTCMKTS: AWKNF) for Severe Alcohol Use Disorder (SAUD).

AWKNF

Read More
1 minute read
  • General
  • Health Care
  • Legal
  • Movers
  • News

Why Is Cancer Blood Test-Focused Guardant Health Stock Trading Lower Today?

By Vandana Singh
November 15, 3:28 PM
Guardant Health Inc (NASDAQ: GH) shares are falling after the company announced it intends to appeal its verdict in the U.S.

GH

Read More
3 minute read
  • Cannabis
  • Earnings
  • Legal
  • Markets
  • News
  • Penny Stocks

California Weed Co. Settles Debt And Celebrates Turn-Around In Q3

By Jelena Martinovic
November 15, 1:01 PM
Unrivaled Brands, Inc. (OTCQB: UNRV) reported its third quarter financial results Tuesday for the three months ended Sept. 30, 2023, revealing an 11.4% year-over-year drop in revenue to $8.6 million.

UNRV

Read More
3 minute read
  • Legal
  • News

Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering; Enova Has Agreed To Pay A $15M Civil Money Penalty

By Benzinga Newsdesk
November 15, 10:17 AM
Errors have been addressed and a settlement, aligned with current Enova business practices, has been reachedCHICAGO, Nov. 15, 2023 /PRNewswire/ -- Enova International, Inc. (NYSE:ENVA), a leading financial technology

ENVA

Posts pagination

Previous 1 … 61 62 63 … 258 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service